Neuroimaging Researcher | LMU Munich | Institute for Stroke and Dementia Research | studying disease mechanisms in Alzheimer’s disease and primary tauopathies
Nico Franzmeier
Loading...
🔥Recent advances in #neuroimaging of #Alzheimers disease 🧠✨
dx.doi.org/10.1002/alz....
➡️ Valuable resource for both researchers & clinicians!
➡️ ATNIV biomarkers, staging, connectomics & more
➡️ Plus: how are sex & country represented in first/last authorship?
@istaart.bsky.social Neuroimaging PIA
Out now in Brain: Our new study shows that tau deposits in Alzheimer’s disease not affect gray matter but also drive degeneration of connected white matter tracts, offering mechanistic insight into how tau disrupts brain networks
academic.oup.com/brain/articl...
New paper out!
We systematically compared how ATN biomarker changes track cognitive decline in AD:
Tau-PET, plasma ptau217 & cortical thickness changes track cognition, amyloid-PET does not.
Ptau217 = cost-effective proxy for monitoring cognitive changes in AD
doi.org/10.1002/alz....
Julie Ottoy
I have just dropped a new version of my academicdb project, which helps prolific researchers generate a CV automatically. Now with a web interface! If you are interested, please try it out and let me know what you think - it takes a bit of setup work but then runs easily using Docker.
🚨Postdoc position open at @BarcelonaBeta🚨
We're looking someone to work on a project at the intersection of cardiovascular and neurodegenerative research 🫀🧠
Fully funded position!!!
More details: www.imim.cat/media/upload...
Please share!
#Alzheimer's #ENDALZ
neuromapr 0.2.1 has been accepted and published on CRAN!
Very excited to get this out to users in the simplest way possible, and hope the #rstats #neuroimaging community finds it useful!
lcbc-uio.github.io/neuromapr/
Nico Franzmeier
Nico Franzmeier
Gemma Salvadó
Russ Poldrack
ᴅʀ. ᴍᴏᴡɪɴᴄᴋᴇʟ'ꜱ
Project to maintain a database for CV/website rendering - poldrack/academicdb
INTRODUCTION
With anti-amyloid beta (Aβ) therapies approved for Alzheimer's disease (AD), surrogate biomarkers are needed to monitor clinical treatment efficacy. Therefore, we systematically compare.....
Implements spatial null models and coordinate-space transformations for statistical comparison of brain maps, following the framework described in Markello et al. (2022)…
